Avandia Lawsuit Heart Attack Attorney
Avandia Heart Attack
Avandia Gets New Warning From Experts in EU
Category: Avandia Heart Attack
Today European regulators added new warnings for GlaxoSmithKline's type-2 diabetes drug Avandia. The warnings recommend that patients with heart disease or leg pains should not take the drug. People who suffer from angina or who have had heart attacks are also advised to not take Avandia.
Continue reading "Avandia Gets New Warning From Experts in EU"
Report Puts Excess Avandia Heart Attacks at 83,000
Category: Avandia Heart Attack
A November report by the Senate Finance Committee, based on the analysis of Avandia by FDA scientists, estimates that Avandia has caused around 83,000 excess heart attacks since coming on the market in 1999. The statistics were presented at a July 30, 2007, safety panel meeting of experts to decide if Avandia should remain on the market. The panel did recommend that Avandia Remain on the market, but hit the type-2 diabetes medication with strictest warning the can issue, the infamous "black box" warning.
Continue reading "Report Puts Excess Avandia Heart Attacks at 83,000"
Yet Another Study Finds Elevated Heart Attack Risk for Avandia
Category: Avandia Heart Attack
Over the past several months the controversy surrounding the popular type-2 diabetes medication Avandia has been building. An article published in May suggested an 42 percent increased risk of heart attack associated with the drug. Today another article published in the Journal of the American Medical Association conveys similar findings adding more fuel to the fire. The article is based on an independent study of thousands of older people with diabetes and its findings show a significant increased risk of heart attack among those treated with Avandia.
Continue reading "Yet Another Study Finds Elevated Heart Attack Risk for Avandia"
Concerns Prompt Two Healthcare Providers to Drop Avandia
Category: Avandia Heart Attack
Yesterday two U.S. pharmacy benefit services removed Avandia from their formularies due to safety concerns. Prime Therapeutics and HealthTrans made the decisions after careful analysis of safety data and efficacy analysis. This removal follows an October announcement by the U.S. Department of Veterans Affairs of a plan to restrict the use of Avandia. The drug was thrown into the public spotlight in May when a New England Journal of Medicine article linked Avandia to a 43 percent increased risk of heart attack. Since that time Avandia has received two "black box" warnings from the FDA, to inform consumers of potential risks.
Continue reading "Concerns Prompt Two Healthcare Providers to Drop Avandia"
Allegations of Intimidation From GSK
Category: Avandia Heart Attack
GlaxoSmithKline is facing fresh allegations detailed in a report submitted to the Congressional Record by high-ranking Senators, Baucus and Grassley. The report claims that GSK representatives made attempt to silence a university professor from speaking about his less than favorable opinion of the type-2 diabetes medication Avandia. John Buse claims that he was intimidated by employees working for GSK after raising concerns about possible cardiovascular risks associated with Avandia. Lawmakers are concerned that this could be a growing trend among big pharma and quick to protect whistleblowers from corporate pressure.
Glaxo's Avandia Hit With FDA's Toughest Warning, Again
Category: Avandia Heart Attack
Yesterday the FDA and GlaxoSmithKline agreed to add an additional warning on the diabetes medication Avandia. The new warning will advise patients of the possible increased risk of heart attack that has been associated with Avandia. In May an article published in the New England Journal of Medicine suggested that Avandia might be tied to a 43 percent increased risk of heart attack. While the study has not yet been confirmed, it also cannot be denied. The wording of the new "black box" warning suggest that the results of the studies are conclusive but merely warn of potential increased risk.
Continue reading "Glaxo's Avandia Hit With FDA's Toughest Warning, Again"
Avandia Gets "Black Box" Warning for Heart Attack Risk
Category: Avandia Heart Attack
Today the FDA announced that they would be adding an addition black box warning to the diabetes medication Avandia. The move has been speculated about for several months now and today has finally been put into action. The new warning will warn of a potential increased risk of heart attack associated with the drug. A May journal article linking Avandia to a 43 percent increased risk in heart attack spawned the concern. The FDA urges patients with underlying heart conditions to consult their physicians to evaluate treatment options.
Continue reading "Avandia Gets "Black Box" Warning for Heart Attack Risk"
FDA to Decide on Avandia Any Day Now
Category: Avandia Heart Attack
Over the past few months the controversy surrounding Avandia has been difficult to miss. The once blockbuster type-2 diabetes medication has been at the center of health concerns since a May New England Journal of Medicine article linked the drug to an increased risk in heart attack. In July the FDA convened a panel of outside experts that voted to allow Avandia to stay on the market, but placed additional precautions and a black box warning on the drug's label for risk of heart failure. The FDA is now considering an additional black box warning to make patients better aware of the potential risk of heart attack that may be linked to Avandia.
GSK Restricts Avandia Use
Category: Avandia Heart Attack
GlaxoSmithKline has placed new restrictions on the use of the once blockbuster type-2 diabetes medication, Avandia. The move is based on a Health Canada review, suggesting an increased risk of heart complications among some users. The new restrictions are in addition to those imposed by the FDA over the summer resulting from a May New England Journal of Medicine article linking Avandia to a 43 percent increased risk of heart attack in Avandia users.
Second "Black Box" Warning for Avandia?
Category: Avandia Heart Attack
Today the Wall Street Journal reports that FDA is considering adding another "black box" warning, the strongest warning given by the FDA, to the type-2 diabetes medication Avandia. The drug already carries a "black box" warning for heart failure introduced just this summer, after a May New England Journal of Medicine article linked the once blockbuster medication to 43 percent increase in heart attack risks. Avandia sales have plummeted over the past few months and this new attention will undoubtedly deal an even greater blow to the already struggling Avandia market.
Wrongful Death Suit Filed Over Avandia
Category: Avandia Heart Attack
A Texas widow, Peggie Stanford, has filed a wrongful death lawsuit against British pharmaceutical giant GlaxoSmithKline, alleging that the type-2 diabetes medication Avandia, manufactured by the company, caused her husband's death. The lawsuit alleges that GSK was negligent in the marketing of rosiglitazone, sold as Avandia. Stanford claims that GSK recklessly and wantonly failed to warn consumers of the life threatening risks associated with the drug.
New Study Says Actos is Better than Avandia
Category: Avandia Heart Attack
Patients who take Actos, manufactured by Takeda Pharmaceutical, have better control of sugar and lipid levels than those who take GlaxoSmithKline's diabetes drug, Avandia, according to the results of a new clinical trial.
Continue reading "New Study Says Actos is Better than Avandia"
Concerns About Avandia Reaffirmed
Category: Avandia Heart Attack
The popular type-II diabetes medication Avandia has been at the center of controversy all summer long and that has now spread into the fall. A may report said that Avandia increased risk of death by 64 percent and risk of heart attack by 43 percent. This summer the drug was hit with a "black box" warning by the FDA warning of this increased risk. The latest study found in the Lancet journal reaffirms speculations made by previous studies.
Arkansas Man Files Lawsuit Against GSK for Heart Problems
Category: Avandia Heart Attack
An Arkansas resident blames Avandia, a type II diabetes treatment medication for heart problems he suffered, according to a lawsuit filed in the federal court of the Western District of Arkansas.
Continue reading "Arkansas Man Files Lawsuit Against GSK for Heart Problems"
More Experts Call for Avandia to be Pulled from Market
Category: Avandia Heart Attack
In light of recent events swirling around the type-II diabetes medication, Avandia, more physicians are calling for the drug to be removed from the market entirely. A study released earlier this year concluded that Avandia carries a 42 percent increase in heart attacks and a doubled risk of heart failure amongst its users. More recent concerns show an increased risk in bone fracture in women taking the drug. Concerns about a possible link to an increased risk of blindness have also been referenced. There have also been questions about the efficacy of the drug pertaining to controlling blood sugar levels.
Continue reading "More Experts Call for Avandia to be Pulled from Market"
New Study Says Avandia is Most Dangerous During the First Year of Use
Category: Avandia Heart Attack
A new study confirms that Avandia (rosiglitazone), a popular drug for treating type II diabetes, is as dangerous as previous studies have stated.
Continue reading "New Study Says Avandia is Most Dangerous During the First Year of Use"
New Study Reaffirms Avandia Dangers
Category: Avandia Heart Attack
A new study released by the American Journal of Medicine adds even more fuel to raging blaze that has engulfed Avandia in recent months. The new study involved almost 15,000 patients and was a randomized control study, meaning that it used both subjects taking the drug and a control group. This is generally seen as the most accurate and effective way to perform a study of this nature. The study concluded that those taking Avandia for 12 months or more have a significantly increased risk of myocardial infarction and heart failure.
More Deceit from GlaxoSmithKline
Category: Avandia Heart Attack
Two British pension funds are vying to be lead plaintiffs in a U.S. class action lawsuit filed against GlaxoSmithKline for misleading investors about the risks of Avandia. The North Yorkshire Pension Fund and the Avon Pension Fund manage about $6 billion of their members assets. Many GlaxoSmithKline investors are dissatisfied with the companies share prices since the New England Journal of Medicine published a study linking one of their best selling drugs, Avandia, to an increased risk of heart failure.
New Heart Attack Claims Against Avandia
Category: Avandia Heart Attack
A new research paper published in the Journal of the American Medical Association shows that patient's who take the type2 diabetes drug, Avandia, are 42 percent more likely to suffer a heart attack then those included in the control group, according to the Wall Street Journal.
GlaxoSmithKline Updates Avandia Prescribing Info
Category: Avandia Heart Attack
Recently, GlaxoSmithKline (GSK) announced the US Food and Drug Administration (FDA) approved updated prescribing information for thiazolidinediones (TZD) class of medicines which are used for Type2 diabetes treatment. The approval will allow GSK to make changes to Avandia's black box warning.
Continue reading "GlaxoSmithKline Updates Avandia Prescribing Info"
Avandia: New Label, Same Problems
Category: Avandia Heart Attack
The diabetes medication Avandia was recently hit with FDA's strongest warning label in response to the increased risk of heart failure associated with the drug. The drug did carry a warning for heart failure at the time of it's release; however, The FDA felt that this warning was not strong enough to truly caution consumers about possible heath risks connected to the drug.
Avandia to Carry Stronger Heart Failure Warnings
Category: Avandia Heart Attack
The Food and Drug Administration (FDA) announced yesterday that the popular diabetes drug, Avandia, will now carry stronger heart failure risk warnings. Avandia, marketed by GlaxoSmithKline, is a class of drugs called thiazolidinediones that will all carry the black box warning.
Continue reading "Avandia to Carry Stronger Heart Failure Warnings"
New Study Questions Avandia's Heart Risk
Category: Avandia Heart Attack
In a study in the New England Journal of Medicine, in June, a heart expert and chairman of the Cleveland Clinic Department of Cardiovascular Medicine reported a 43 percent increased risk of heart attack amongst patients who take Avandia (rosiglitazone), to treat type-2 diabetes. The risk was discovered amongst 42 studies that he analyzed.
Avandia: Increased Heart Attack Risks
Category: Avandia Heart Attack
Cleveland Clinic called Avandia's safety into question in May, after analysis linked the drug to a 43 percent higher chance of suffering a heart attack while taking Avandia to treat type2 diabetes.
Avandia Lawsuit Filed in Federal Court
Category: Avandia Heart Attack
A wrongful death lawsuit has been filed in federal court against GlaxoSmithKline, the manufacturer of Avandia, a diabetes treatment drug believed to increase the risk of heart attacks.
Type 2 diabetic, Larry S., died of a heart attack on May 21, 2007, the same day the article published in the New England Journal of Medicine claimed the prescription drug, Avandia, increases one's chance of suffering a heart attack.
Nothing new about controversy over medications
Category: Avandia Heart Attack
The current controversy swirling around the diabetes drug Avandia is reminiscent of a similar controversy that arose more than 30 years ago. Then, as now, a study showed that a popular diabetes drug might be causing heart problems instead of preventing them.
Continue reading "Nothing new about controversy over medications"
Diabetes Drug Linked to Heart Attacks, Death
Category: Avandia Heart Attack
Widely prescribed Avandia increases risk by 43 percent, research shows. The widely prescribed diabetes drug Avandia is linked to a greater risk of heart attack and possibly death, a new scientific analysis revealed, and the U.S. government issued a safety alert Monday
Continue reading "Diabetes Drug Linked to Heart Attacks, Death"
Avandia Increases Heart Attack Risk
Category: Other Avandia News
In February 2007, GlaxoSmithKline, released a press release that noted a greater increase of fractures in the upper arms, hands and feet of female diabetics that are taking Avandia, compared to those taking other diabetic medication. The information was discovered in data from an ADOPT trial.
FDA Issues Avandia Safety Alert
Category: Avandia Heart Attack
The U.S. Food and Drug Administration (FDA) has issued a safety warning regarding Avandia (Rosiglitazone), a drug approved to treat type 2 diabetes. Safety data from controlled clinical trials have indicated a potential increase in the risk of heart attack and heart-related deaths in patients that take Avandia.